These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 2158098

  • 1. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 2. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus.
    Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM.
    Blood; 1999 Aug 15; 94(4):1372-81. PubMed ID: 10438725
    [Abstract] [Full Text] [Related]

  • 8. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
    Khanna R, Jacob CA, Burrows SR, Kurilla MG, Kieff E, Misko IS, Sculley TB, Moss DJ.
    Immunology; 1991 Nov 15; 74(3):504-10. PubMed ID: 1722774
    [Abstract] [Full Text] [Related]

  • 9. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ.
    J Exp Med; 1990 Jan 01; 171(1):345-9. PubMed ID: 1688611
    [Abstract] [Full Text] [Related]

  • 10. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB.
    J Exp Med; 1993 Sep 01; 178(3):879-87. PubMed ID: 7688791
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB.
    J Virol; 1989 Mar 01; 63(3):1031-9. PubMed ID: 2536817
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 01; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 14. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children.
    Tamaki H, Beaulieu BL, Somasundaran M, Sullivan JL.
    J Infect Dis; 1995 Sep 01; 172(3):739-46. PubMed ID: 7658067
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.
    J Virol; 1988 Oct 01; 62(10):3747-55. PubMed ID: 2843672
    [Abstract] [Full Text] [Related]

  • 16. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB.
    J Virol; 1993 Dec 01; 67(12):7428-35. PubMed ID: 7693972
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection.
    Khanna R, Jacob CA, Burrows SR, Moss DJ.
    J Immunol Methods; 1993 Aug 26; 164(1):41-9. PubMed ID: 7689619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.